Casey E. Stowers

Casey E. Stowers

Auto-generated profile, based on publicly available information

Casey E. Stowers

Oden Institute for Computational Engineering and Sciences, The University of Texas at Austin, Austin, USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2021 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
CSCasey Stowers
Casey Stowers
TLTaeksang Lee
Taeksang Lee
IBIlias Bilionis
Ilias Bilionis
AGArun K. Gosain
Arun K. Gosain
ATAdrian Buganza Tepole
Adrian Buganza Tepole

1 January 2025 in Radiology: Artificial Intelligence
Verified
Journal Article
Closed access
CSCasey E. Stowers
Casey E. Stowers
CWChengyue Wu
Chengyue Wu
ZXZhan Xu
Zhan Xu
SKSidharth Kumar
Sidharth Kumar
CYClinton Yam
Clinton Yam
TYThomas Yankeelov
Thomas Yankeelov
A convolutional neural network combined with a biology-based mathematical model showed good performance in predicting the triple-negative breast cancer response to neoadjuvant chemotherapy using only pretreatment MRI data.

26 August 2025 in Clinical Cancer Research
Verified
Journal Article
Closed access
RPReshmi J. S. Patel
Reshmi J. S. Patel
CWChengyue Wu
Chengyue Wu
CSCasey E. Stowers
Casey E. Stowers
RMRania M. Mohamed
Rania M. Mohamed
JMJingfei Ma
Jingfei Ma
TYThomas Yankeelov
Thomas Yankeelov
Purpose: We seek to establish the generalizability of our biology-based mathematical model in accurately predicting the response of patients with locally advanced breast cancer to neoadjuvant therapy (NAT). Experimental Design: Ninety-one patients (representing three subtypes of locally advanced breast cancer) from 10 Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging and Molecular Analysis 2 (I-SPY 2) clinical trial sites received quantitative MRI before (V1), 3 weeks into (V2), and after completion of (V3) the first 12-week standard-of-care or experimental NAT course. We used these data to calibrate, on a patient-specific basis, our previously developed biology-based mathematical model describing the spatiotemporal change in the number of tumor cells. After calibrating the mathematical model to the V1 and V2 MRI data, the calibrated model predicted the patient-specific tumor status at V3 by explicitly accounting for tumor cell movement (constrained by the mechanical properties of the surrounding tissue), proliferation, and death due to treatment. Results: The concordance correlation coefficient between the observed and predicted tumor change from V1 to V3 was 0.94 for total cellularity and 0.91 for volume. A logistic regression model of predicted tumor volume metrics from V1 to V3 differentiated pathologic complete response from nonpathologic complete response patients with an area under the ROC curve of 0.78. Conclusions: Our tumor forecasting pipeline can accurately predict tumor status after an NAT course—on a patient-specific basis, without a training dataset—using “real-world” MRI data obtained from a multi-subtype, multisite clinical trial.

14 November 2025
Verified
Other
Open access
PDF file
RPReshmi J. S. Patel
Reshmi J. S. Patel
CWChengyue Wu
Chengyue Wu
CSCasey E. Stowers
Casey E. Stowers
RMRania M. Mohamed
Rania M. Mohamed
JMJingfei Ma
Jingfei Ma
TYThomas Yankeelov
Thomas Yankeelov
Summary of tumor response prediction accuracy with local drug efficacy model


14 November 2025
Verified
Other
Open access
PDF file
RPReshmi J. S. Patel
Reshmi J. S. Patel
CWChengyue Wu
Chengyue Wu
CSCasey E. Stowers
Casey E. Stowers
RMRania M. Mohamed
Rania M. Mohamed
JMJingfei Ma
Jingfei Ma
TYThomas Yankeelov
Thomas Yankeelov
Local drug efficacy model summary results